Summary To invade and metastasize, carcinomas must penetrate or lose their epithelial basement membrane (EBM), and then penetrate basement membranes (BMs) surrounding blood vessels, lymphatics, nerves and muscle cells. Knowledge of the composition of different BMs is necessary, so that appropriate antibodies and DNA probes are used to analyse these events. Laminin and type IV collagen are the principal BM components. However, recent studies show these two proteins exist in various isoforms, each of which is a heterotrimer of different subunit polypeptides. In this study, we analysed the distribution of laminin subunits, ax1 (lam), ax2(lam), f1 (lam), P2(lam) and yl (lam), and collagen IV subunits, cr1 (IV), a3(IV), ca4(IV) and c5(IV), in normal and neoplastic tissues of colorectum and breast. Subunits ca1 (IV), ca1 (lam), fl (lam) and yl (lam) were detected in all BMs, while the distribution of a3(IV), ax4(IV), a5(IV) and ax2(lam) was much more restricted. In carcinomas, EBM staining for all subunits was invariably discontinuous or absent, consistent with the presence of complete EBM breaks. Use of antibody to cr1 (lam) selectively stained the EBMs of carcinomas. Strong vascular staining for ac1 (lam), 1l (lam), yl (lam) and a1 (IV) suggests an abundance of BM proteins in vessel walls, which may aid tumour cell attachment before vascular invasion. Within carcinomas, vascular BM staining for 12(lam) was clearly weaker than in normal tissues, which may reflect incomplete maturation of these vessels.
Following the report that epithelial basement membrane (EBM) breaks are associated with the malignant phenotype in epithelial tumours , there has been intense interest in the diagnostic and prognostic significance of these breaks, and the literature on this subject is extensive [reviewed by D'Ardenne (1989) and Bosman (1994) ]. Such studies on human colorectal (Forster et al, 1986; Havenith et al, 1988; Hewitt et al, 1991) and breast cancer (Albrechtsen et al, 1981; Barsky et al, 1983 ) have shown marked EBM deficiencies. These studies have generally involved immunocytochemical staining for either of the major basement membrane proteins, laminin or collagen IV.
Recently, it has been found that laminin and collagen-IV exist in a variety of isoforms with different subunit compositions. However, practically the entire literature on basement membranes in cancer is based on immunocytochemical studies using antibodies that do not discriminate between these different subunits.
The classical collagen IV molecule is composed of two crl (IV) subunits and one oc2(IV) subunit, which together form a triple helix. Novel collagen IV subunits have been found more recently, and these include the oc3(IV), cx4(IV) and cx5(IV) subunits (Tryggvason et al, 1993) . The laminin molecule is also a heterotrimer of different subunits . In classical laminin, the subunits were originally designated A, B I and B2, but have recently been renamed crl, Pi and yl respectively (Burgeson et al, 1994) . Subunits M and S, which were described in novel isoforms of laminin, have been renamed oc2 and P2 respectively.
All isoforms of laminin appear to contain one oc chain, one A chain and one y chain. To avoid confusion with the collagen IV subunits, the laminin subunit names will be given the suffix '(lam)' in this article.
In a recent in situ hybridization study by Pyke et al (1994) , mRNA for the novel y2(lam) subunit was found to be specifically overexpressed by actively invading neoplastic cells in both colorectal and breast carcinomas. This finding may have prognostic significance and underlines the need for detailed studies on the expression of different laminin and collagen IV subunits in cancer. Studying the expression of these subunits in basement membranes around normal structures, such as blood vessels and nerves, may also offer clues to understanding the invasive behaviour of cancers, as there is accumulating evidence that basement membranes regulate the differentiation and behaviour of adjacent cells (Klein et al, 1988; Van Den Hooff, 1989; Sorokin et al, 1990) .
We have therefore carried out a descriptive study on normal and neoplastic tissues of colorectum and breast to document for the first time the distribution of the following subunits of collagen IV: crl(IV), oc3(IV), cr4(IV), cr5(IV); and laminin: crl(lam), cr2(lam), , 1(lam), P2(lam) and yl (lam).
MATERIALS AND METHODS Antibodies
Anti-collagen IV antibodies used were rabbit polyclonal antiserum raised against human placental collagen-IV and monoclonal clone 1042 (Euro-Path Bude, UK), monoclonal CIV22 (Dako, Bucks, UK) and monoclonal antibodies MAb AI 0, MAb A2, MAb 85 and MAb A7 (gifts from Dr AF Michael). The polyclonal and monoclonals, clone 1042 and CIV22, are non-subunit specific. MAb A7 recognizes the cx5(IV) subunit, which is the same molecule as the Alport antigen (Ding et al, 1994) . Monoclonals to the cx2(IV) subunit have been difficult to produce, and none were available (Ellis et al, 1992) . The samples included normal breast tissue in five cases, fibroadenoma in two cases and eight cases of breast carcinoma (three cases of carcinoma of no special type, one tubular carcinoma, one tubular mixed carcinoma, one atypical medullary carcinoma and two lobular carcinomas). Ductal carcinoma in situ (DCIS) was present in five sections of carcinoma, and lobular carcinoma in situ (LCIS) was present in one case. To obtain sections from healing wounds, tissue samples were taken from three mastectomy specimens in which lumpectomy had been performed 23-25 days previously. Samples of normal human kidney were obtained at post mortem. All tissue samples were quenched in isopentane precooled in liquid nitrogen and stored at -70°C until required for sectioning. Cryostat sections of 4-5 ,um were cut, air dried and then fixed in 95% ethanol for 5 min at 4°C. Those sections to be stained with MAb85 and MAb A7 specifically were then denatured (presumed to expose buried epitopes) by incubation in 6M urea, 0. lM glycine HCl, pH 3.5 for I h at 4°C (Yoshioka et al, 1985) . All sections were then rinsed three times with phosphate-buffered saline (PBS) at room temperature, before staining using a two-step indirect immunoperoxidase method as described previously (Hewitt et al, 1992) .
Sections of normal human kidney were used as a tissue control to demonstrate the reliability of antibody preparations. To test the specificity of staining reactions, sections of colorectal and breast tissue were stained, but with the omission of the primary antibody.
RESULTS
Control sections of human kidney Glomerular BM staining was seen for all antibodies, except those specific for al(IV), l(lam) and ox2(lam), which instead showed prominent mesangial matrix staining (Figure 1 ). Both proximal and distal tubular BMs were stained by all antibodies against al(lam), Pl(lam) and yl(lam), and by anti-al(IV). Only the distal tubular BMs stained for x3(IV) and x4(IV), and no other novel laminin and collagen-IV subunits were detected in tubular BMs. These results are generally consistent with previous reports (Kleppel et al, 1989; Sanes et al, 1990) and confirm that all antibodies used in this study were working effectively for immunocytochemistry.
EBM
In normal and neoplastic colorectal tissues (see Table 2 and 
Not all cases of breast carcinoma are represented, but scores for tubular and atypical medullary carcinomas followed the same pattern as shown for the NST carcinomas. The tubular mixed carcinomas only showed weak staining with the collagen-IV polyclonal and monoclonals, 1042 and CIV22. The LCIS showed a similar pattern to the cases of DCIS. Scoring of staining intensity: 3+, strong; 2+, moderate; +, weak; -absent; -/3+, strong but discontinuous. NM, normal colorectal mucosa; A, colorectal adenoma; C, colorectal carcinoma; N, normal breast tissue; F, fibroadenoma; NST, carcinomas of no special type; L, lobular carcinoma. b gland base;s surface epithelium;', focal. Smooth muscle cells of muscularis mucosae and propria in the colorectum showed moderate or strong staining for all antigens studied (Figure 2) , with the exception of oc2(lam), a3(IV), ax4(IV) and ax5(IV), for which there was no staining.
Cells with dendritic-type morphology having multiple long thin processes were also observed between the glands in normal colorectal mucosa (Figure 2A ). These cells were most obvious in sections stained with antibody to ax2(lam), as this did not stain neighbouring structures such as EBM, blood vessels or muscular layers of the bowel wall. Preliminary ultrastructural studies suggest that these unusual cells with multiple processes are myofibroblast-like (T Gray and RE Hewitt, unpublished observations).
In both colorectal and breast carcinomas, stromal myofibroblasts showed weak or absent staining for ocl(lam) (see Figure 5 ), despite moderately strong staining for 1 (lam) and yl (lam) subunits and for ocl(IV). In sections stained for ocl(lam), the EBMs are therefore especially prominent.
DISCUSSION
There have been many immunocytochemical studies on basement membrane staining in colorectal and breast neoplasms. However, with only a very few exceptions, the anti-laminin and anti-collagen IV antibodies used in such studies have been non-subunit specific. Now that subunit-specific antibodies and DNA probes are available, it is possible to obtain more detailed and meaningful information about the interactions between tumour cells, their EBMs and other basement membranes they encounter. For example, in a previous in situ hybridization study using a cDNA probe for oxl (IV) (Hewitt et al, 1992) , we found that the hybridization signal was entirely localized to blood vessels. This raised the possibility that the collagen IV demonstrated in the EBMs by immunocytochemistry might consist of novel collagen IV isoforms. However, in the light of our present results this seems less likely, as the EBMs of colorectal carcinomas stained for the xl(IV) subunit of classical collagen IV, but not for a3(IV), a4(IV) and cx5(IV). Pyke et al ( 1994) have recently reported an in situ hybridization study using probes for oxl(lam), [l(lam) and yl(lam) to analyse colonic cancers. In the 16 colon carcinomas studied, the hybridization signal for these three probes was weak and was consistently localized both to stromal cells with fibroblast-like morphology and to the endothelial cells of small vessels. These findings are consistent with the results of the present study, in that xl(lam), [l(lam) and yl(lam) were all detected in blood vessel walls by immunocytochemistry. Presumably, endothelial cells contribute to the synthesis of laminin deposited in the blood vessel wall. Pyke et al (1994) never found expression of c I (lam), [ 1 (lam) and yl (lam) in neoplastic cells of colon cancers, which may indicate that EBM laminin in these tumours is derived mainly or entirely from stromal fibroblasts. As mentioned previously, Pyke et al (1994) did find a marked increase in y2(lam) expression in neoplastic cells at the invasive edge of colorectal cancers. We did not find evidence for any similar increases in expression of laminin or collagen-IV subunits, although y2(lam) was not examined in this study.
EBM staining patterns
In non-malignant tissues of both colorectum and breast tissue, we have found obvious EBM staining for subunits of classical laminin This abundance of BM proteins may facilitate tumour cell attachment to the walls of blood vessels, which may in turn lead to dissolution of the vessel wall and penetration into the vascular lumen, according to the 'three-step' hypothesis of invasion ).
While vascular staining for P2(1am) was prominent in nonmalignant tissues of breast and colorectum, it was often weak or absent in the vessels within carcinomas. Interestingly, we also found that the newly formed and poorly differentiated blood vessels of healing wounds showed deficient 12(lam) staining.
There is abundant evidence that blood vessels of carcinomas show incomplete differentiation, as they are often dilated with irregular endothelial linings, scanty perivascular connective tissues and tortuous, disorganized courses (Willis, 1973; Denekamp, 1983) . Furthermore, in an extensive study on human tumours, Lindgren (1945) found that vascular architecture was most abnormal in the less well-differentiated malignant tumours. It is therefore possible that the low level of vascular staining for P2(lam) in carcinomas is a result of the incomplete differentiation of the tumour blood vessels. Although vascular staining in colorectal and breast tissues showed generally similar patterns, a difference was seen with respect to staining for the oc5(IV) subunit. In colorectal tissues, only the autonomic nerves and ganglia stained for this antigen. However, in normal breast tissue there was weak staining of capillaries and larger blood vessels, and moderately strong vascular staining was seen in fibroadenomas. This suggests a difference in BM composition between blood vessels of normal colorectal and breast tissues.
We previously used an ax(IV) subunit cDNA probe for an in situ hybridization (ISH) study on colorectal carcinomas (Hewitt et al, 1992) and found a high level of mRNA expression in some tumour blood vessels, but no detectable expression in any other tumour component. This pattern of expression seems consistent with the present immunocytochemical results, which suggest that the ot 1 (IV) subunit is more abundant in the walls of tumour blood vessels than in the EBM or any other tumour component. It may be relevant that blood vessels in some cancers produce high levels of the protease inhibitor, plasminogen activator inhibitor 1 (PAI-1), and it has been hypothesized that this is part of a protective response to prevent proteases produced within the tumour from degrading the tumour's own vascular connective tissue stroma (Kristensen et al, 1990) . The high levels of collagen IV production in blood vessels of colorectal cancer (Hewitt et al, 1992 ) may be part of the same protective response.
The significance of differences in BM composition
The varied laminin and collagen-IV subunit composition of different BMs raises the interesting question of why there should be a biological need for this level of complexity. One reason may be that different subunits impart different physical properties to BMs, such as differences in permeability. For example, in the kidney, the high volume unidirectional transfer of fluid may be facilitated by the high levels of novel collagen IV subunits in the glomerular BMs (Kleppel et al, 1989) . Another reason for the complexity may be that different subunits may have important regulatory effects on the biological activities of adjacent cells.
Supporting evidence comes from the fact that f2(lam), unlike 0 1 (lam), contains sequences selective for the attachment of motoneurones . As P2(lam) is abundant in synaptic BM, this may explain why the regenerating axons in denervated muscle preferentially form neuromuscular junctions at the original synaptic sites (Hunter et al, 1989) . P2(lam) therefore appears to have very specific effects on the behaviour of at least one cell type. The selective loss of f2(1am) from epithelial and vascular BMs in cancers, observed in the present study, may therefore have important effects on the behaviour of adjacent neoplastic and endothelial cells.
CONCLUSION
The findings of this study show that the o2(lam) subunit and the novel chains of collagen-IV [a3 (IV), o4 (IV) and ax5(IV)] show limited expression in normal and neoplastic tissues of colorectum and breast. In contrast, the subunits of classical laminin [(Xl (lam) , 31 (lam) and yl(lam)] and the ax(IV) chain are very widely distributed in the basement membranes of these tissues. To our knowledge, this is the first immunocytochemical study to document the distribution of any of the subunits of laminin and collagen IV in either colorectal or breast cancer. It is hoped that the information presented here will provide a useful reference point for future investigations.
